Skip to main content

Table 3 Characteristics of type 1 diabetes patients according to the genotypes of CYBA -675 T → A (unregistered) or GCLC rs17883901 SNPs.

From: Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus

 

CYBA

TT

(n = 353)

CYBA

TA+AA

(n = 48)

Pvalue

GCLC

CC

(n = 331)

GCLC

CT+TT

(n = 70)

pvalue

Sex (male/female) (%)

45/55

43/57

0.4334

53/47

38/62

0.1259

Age (years)

34.6 (27.7-43)

33 (27.8-43)

0.4778

35 (27.9-44)

34.6 (27.1-42)

0.6965

Age at diabetes diagnosis (years)

12 (7-19)

13 (10-19)

0.3466

13 (7.5-20)

11 (7-15.2)

0.0073

Duration of diabetes (years)

21 (16.4-26)

20.3 (16-27)

0.7917

21 (16.6-26)

21.6 (17-29.4)

0.6799

Arterial hypertension (%)

45.6

44.9

0.5250

46.1

43.4

0.3937

Use of lipid-lowering drugs (%)

19

15.7

0.3583

17.4

25.3

0.1336

Use of ACE inhibitors (%)

21.1

18.3

0.4068

18.8

31.4

0.0164

HbA1C (%)

8.4 (7.4-9.6)

8.25 (7.2-10)

0.6329

8.3 (7.3-9.8)

8.3 (7.3-9.3)

0.9669

Cholesterol (mg/dL)

173 (150-200)

180 (149.5-209)

0.4319

174 (149-201)

174 (157-197)

0.7560

HDL cholesterol (mg/dL)

55 (46-67)

58 (47-69)

0.2954

57 (47-68)

52 (43-64.5)

0.0986

LDL cholesterol (mg/dL)

95 (78-118)

97 (75.2-124.4)

0.7686

94.4 (78-119)

94.2 (78-116)

0.8902

Triglycerides (mg/dL)

82 (58-118)

73 (54-113)

0.4712

80 (57-119.2)

85.5 (58-114.2)

0.3683

Overt DN (%)

36.2

20

0.0398

33.6

40

0.2387

GFR < 60 mL/min (%)

35.3

18.7

0.0143

31.1

47.1

0.0082

  1. Data are median ± interquartile interval; ACE: angiotensin converting enzyme; DN: diabetic nephropathy; GFR: glomerular filtration rate.